What's in Seung-Jung Park's pipeline?

Seung-Jung Park has 5 drugs in our index: 5 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Seung-Jung Park's portfolio?

Top competitors by shared drug class: Sanofi, Ahn-Gook Pharmaceuticals Co.,Ltd, Boryung Pharmaceutical Co., Ltd, Azienda Policlinico Umberto I, Beijing Tide Pharmaceutical Co., Ltd.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/seung-jung-park.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Seung-Jung Park — Portfolio Competitive Intelligence Brief

Seung-Jung Park pipeline: 5 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
optimal medical therapy	optimal medical therapy	marketed
Pregrel®	Pregrel®	marketed
Rosuvastatin calcium 40mg	Rosuvastatin calcium 40mg	marketed
Clopidogrel only	Clopidogrel only	marketed	P2Y12 receptor antagonist / Thienopyridine antiplatelet agent	P2Y12 receptor	Cardiovascular
Optimal Medical treatment	Optimal Medical treatment	marketed	ACE inhibitor	Angiotensin II receptor	Cardiovascular

Therapeutic area mix

Cardiovascular · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Sanofi · 2 shared drug classes
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Boryung Pharmaceutical Co., Ltd · 1 shared drug class
Azienda Policlinico Umberto I · 1 shared drug class
Beijing Tide Pharmaceutical Co., Ltd · 1 shared drug class
Bioprojet · 1 shared drug class
Ain Shams University · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Seung-Jung Park:

Cite this brief

Drug Landscape (2026). Seung-Jung Park — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/seung-jung-park. Accessed 2026-05-16.